author-photo

Beesan Tan

Pfizer

7

Papers

75

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

PF‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study

2019 Clinical and Translational Science
Show All
- Source
- Cite
- Save
Citations (13)
Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A 4-week study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of the glucagon receptor antagonist PF-06291874 administered as monotherapy in subjects with type 2 diabetes mellitus

2017 Diabetes Research and Clinical Practice
Show All
- Source
- Cite
- Save
Citations (15)
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.

2016 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (34)
Discovery of Efficacious Pseudomonas aeruginosa-Targeted Siderophore-Conjugated Monocarbams by Application of a Semi-Mechanistic PK/PD Model

2015
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Body Size and Gender on the Population Pharmacokinetics of Artesunate and Its Active Metabolite Dihydroartemisinin in Pediatric Malaria Patients

2013 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (12)